Skip to main content
Erschienen in: Archives of Orthopaedic and Trauma Surgery 8/2008

01.08.2008 | Orthopaedic Surgery

What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature

verfasst von: Michel P. J. van den Bekerom, Bas Lamme, An Sermon, Michiel Mulier

Erschienen in: Archives of Orthopaedic and Trauma Surgery | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Osteoarthritis (OA) is a disease of the synovial joints and is the most common cause of chronic pain in the elderly. One of the treatment modalities for OA of the hip is viscosupplementation (VS). Today there are several different formulations of viscosupplements produced by different manufactures of different molecular weights. The objective of this review is to asses the efficacy of VS treatment of hip OA osteoarthritis in the current literature.

Material and methods

The following databases were searched: Medline (period 1966 to November 2006), Cochrane Database of Systematic Reviews (1988 to November 2006), Cochrane Clinical Trial Register (1988 to November 2006), Database of Abstracts on Reviews and Effectiveness, Current Controlled Trials, National Research Register and Embase (January 1988 to November 2006). The search terms [osteoarthritis, hip (joint), viscosupplementation, hyaluronic acid, hyaluronan, sodium hyaluronate and trade names] were applied to identify all studies relating to the use of VS therapy for OA of the hip joint.

Results

Sixteen articles concerning the efficacy of a total of 509 patients undergoing VS treatment for hip OA were included. Twelve European studies, three Turkish studies and one American study with Levels of Evidence ranging from I to IV evaluated the following products: Hylan G-F 20, Hyalgan®, Ostenil®, Durolane®, Fermatron® and Orthovisc®. Heterogeneity of included studies did not allow pooled analysis of data.

Discussion

Despite the relatively low Level of Evidence of the included studies, VS performed under fluoroscopic or ultrasound guidance seems an effective treatment and may be an alternative treatment of hip OA. Intra-articular injection of (derivatives of) HA into the hip joint appears to be safe and well tolerated. However, VS cannot be recommended as standard therapy in hip OA for wider populations, and therefore the indications remain a highly individualised matter.
Literatur
1.
Zurück zum Zitat Adams ME (1993) Viscosupplementation: a treatment for osteoarthritis. J Rheum 20(suppl 39):2 Adams ME (1993) Viscosupplementation: a treatment for osteoarthritis. J Rheum 20(suppl 39):2
2.
Zurück zum Zitat American Academy of Orthopaedic Surgeons (AAOS), Council of Musculoskeletal Specialty Societies (COMSS) in Tarpon Springs, Florida, in April 1994 American Academy of Orthopaedic Surgeons (AAOS), Council of Musculoskeletal Specialty Societies (COMSS) in Tarpon Springs, Florida, in April 1994
3.
Zurück zum Zitat Balzas E (1982) The viscoelastic properties of synovial fluid and the special role of hyaluronic acid. In: Heflet A (ed) Disorders of the knee, 2nd edn. JB Lippencott, Philadelphia, pp 61–74 Balzas E (1982) The viscoelastic properties of synovial fluid and the special role of hyaluronic acid. In: Heflet A (ed) Disorders of the knee, 2nd edn. JB Lippencott, Philadelphia, pp 61–74
4.
Zurück zum Zitat Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
5.
Zurück zum Zitat Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. In: The cochrane database of systematic reviews 19(2), Art No.: CD005321 Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. In: The cochrane database of systematic reviews 19(2), Art No.: CD005321
6.
Zurück zum Zitat Bellamy N, Kirwan J, Boers M et al (1997) Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 24(4):799–802PubMed Bellamy N, Kirwan J, Boers M et al (1997) Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 24(4):799–802PubMed
7.
Zurück zum Zitat Berg P, Olsson U (2004) Intra articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22:300–306PubMed Berg P, Olsson U (2004) Intra articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22:300–306PubMed
8.
Zurück zum Zitat Bertolami C, Gay T, Clark G et al (1993) Use of sodium hyaluronate in treating temporo-mandibular joint disorders: a randomized double blind, placebo controlled clinical trial. J Oral Maxillofacial Surg 51:232–242CrossRef Bertolami C, Gay T, Clark G et al (1993) Use of sodium hyaluronate in treating temporo-mandibular joint disorders: a randomized double blind, placebo controlled clinical trial. J Oral Maxillofacial Surg 51:232–242CrossRef
9.
Zurück zum Zitat Bragantini A, Molinaroli F (1994) A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Clin Ther Res 55:3319–3330 Bragantini A, Molinaroli F (1994) A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Clin Ther Res 55:3319–3330
10.
Zurück zum Zitat Brocq O, Tran G, Breuil V et al (2002) Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. An open label study in 22 patients. Joint Bone Spine 69(4):388–391PubMedCrossRef Brocq O, Tran G, Breuil V et al (2002) Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. An open label study in 22 patients. Joint Bone Spine 69(4):388–391PubMedCrossRef
11.
Zurück zum Zitat Caglar-Yagci H, Unsal S, Yagci I et al (2005) Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25(5):341–344PubMedCrossRef Caglar-Yagci H, Unsal S, Yagci I et al (2005) Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25(5):341–344PubMedCrossRef
12.
Zurück zum Zitat Chazerain P, Rolland D, Cordonnier C (1999) Septic hip arthritis after multiple injections into the joint of hyaluronate and glucocorticoid. Rev Rhum (Engl Ed) 6:436 Chazerain P, Rolland D, Cordonnier C (1999) Septic hip arthritis after multiple injections into the joint of hyaluronate and glucocorticoid. Rev Rhum (Engl Ed) 6:436
13.
Zurück zum Zitat Conrozier T, Bertin P, Mathieu P et al (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open label multicentre, pilot study. Clin Exp Rheumatol 21(5):605–610PubMed Conrozier T, Bertin P, Mathieu P et al (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open label multicentre, pilot study. Clin Exp Rheumatol 21(5):605–610PubMed
14.
Zurück zum Zitat Conrozier T, Vignon E (2005) Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? Clin Exp Rheumatol 23:711–716PubMed Conrozier T, Vignon E (2005) Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? Clin Exp Rheumatol 23:711–716PubMed
15.
Zurück zum Zitat De Nies F, Fiddler MW (1997) Visual analog scale for the assessment of total hip arthroplasty. J Arthroplasty 12(4):416–419PubMedCrossRef De Nies F, Fiddler MW (1997) Visual analog scale for the assessment of total hip arthroplasty. J Arthroplasty 12(4):416–419PubMedCrossRef
16.
Zurück zum Zitat Egsmose C, Lund B, Bach Andersen R (1984) Hip joint distension in osteoarthrosis. A triple-blind controlled study comparing the effect of intra-articular indoprofen with placebo. Scand J Rheumatol 13:238–242PubMedCrossRef Egsmose C, Lund B, Bach Andersen R (1984) Hip joint distension in osteoarthrosis. A triple-blind controlled study comparing the effect of intra-articular indoprofen with placebo. Scand J Rheumatol 13:238–242PubMedCrossRef
17.
Zurück zum Zitat Felson DT (1988) Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 10:1–18PubMed Felson DT (1988) Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 10:1–18PubMed
18.
Zurück zum Zitat Fletcher B, Sackett DL (1979) Canadian task force on the periodic health examination: the Periodic Health Examination. CMAJ 121:1193–1254 Fletcher B, Sackett DL (1979) Canadian task force on the periodic health examination: the Periodic Health Examination. CMAJ 121:1193–1254
19.
Zurück zum Zitat Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. J Bone Joint Surg Am 51-A:737–755 Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. J Bone Joint Surg Am 51-A:737–755
20.
Zurück zum Zitat Hochberg MC, Altman RD, Brandt KD et al (1995) Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 38:1535–1540PubMedCrossRef Hochberg MC, Altman RD, Brandt KD et al (1995) Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 38:1535–1540PubMedCrossRef
21.
Zurück zum Zitat Itokazu M, Matsunaga T (1995) Clinical evaluation of high molecular weight sodium hyaluronate for the treatment of patients with peri-arthritis of the shoulder. Clin Ther 17(5):946–955PubMedCrossRef Itokazu M, Matsunaga T (1995) Clinical evaluation of high molecular weight sodium hyaluronate for the treatment of patients with peri-arthritis of the shoulder. Clin Ther 17(5):946–955PubMedCrossRef
22.
Zurück zum Zitat Jadad AR, Moore A, Carroll D et al (1996) Assessing the quality of reports of randomised controlled trials: is blinding necessary? Contr Clin Trials 17:1–12CrossRef Jadad AR, Moore A, Carroll D et al (1996) Assessing the quality of reports of randomised controlled trials: is blinding necessary? Contr Clin Trials 17:1–12CrossRef
23.
Zurück zum Zitat Kopp S, Akerman S, Nilner M et al (1991) Short term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporo-mandibular joint. J Craniomandibular Dis Facial oral Pain 5(4):231–238 Kopp S, Akerman S, Nilner M et al (1991) Short term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporo-mandibular joint. J Craniomandibular Dis Facial oral Pain 5(4):231–238
24.
Zurück zum Zitat Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799PubMedCrossRef Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799PubMedCrossRef
25.
Zurück zum Zitat Leardini G, Perbellini A, Franceschini M et al (1988) Intra-articular injections of hyaluronate acid in the treatment of the painful shoulder. Clin Ther 10:521–525PubMed Leardini G, Perbellini A, Franceschini M et al (1988) Intra-articular injections of hyaluronate acid in the treatment of the painful shoulder. Clin Ther 10:521–525PubMed
26.
Zurück zum Zitat Lequesne M, Mery C, Samson M et al (1987) Indexes of severity for osteoarthritis of the hip and knee. Indexes of severity for osteoarthritis of the hip and knee. Validation and value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85–89PubMedCrossRef Lequesne M, Mery C, Samson M et al (1987) Indexes of severity for osteoarthritis of the hip and knee. Indexes of severity for osteoarthritis of the hip and knee. Validation and value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85–89PubMedCrossRef
27.
Zurück zum Zitat Ling SM, Bathon JM (1998) Osteoarthritis in older adults. J Am Geriatr Soc 46:216–225PubMed Ling SM, Bathon JM (1998) Osteoarthritis in older adults. J Am Geriatr Soc 46:216–225PubMed
28.
Zurück zum Zitat Lo GH, LaValley M, McAlindon T et al (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis—a meta-analysis. JAMA 290(23):3115–3121PubMedCrossRef Lo GH, LaValley M, McAlindon T et al (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis—a meta-analysis. JAMA 290(23):3115–3121PubMedCrossRef
29.
Zurück zum Zitat March LM, Bachmeier CJ (1997) Economics of osteoarthritis: a global perspective. Baillieres Clin Rheumatol 11:817–834PubMedCrossRef March LM, Bachmeier CJ (1997) Economics of osteoarthritis: a global perspective. Baillieres Clin Rheumatol 11:817–834PubMedCrossRef
30.
Zurück zum Zitat Marshall K (1997) The current status of hylan therapy for the treatment of osteoarthritis. Todays ther Trends 15:99–108 Marshall K (1997) The current status of hylan therapy for the treatment of osteoarthritis. Todays ther Trends 15:99–108
31.
Zurück zum Zitat Migliore A, Martin LSM, Alimonte A (2003) Efficacy and safety of viscosupplementation by ultra-sound guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartil 11(4):305–306CrossRef Migliore A, Martin LSM, Alimonte A (2003) Efficacy and safety of viscosupplementation by ultra-sound guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartil 11(4):305–306CrossRef
32.
Zurück zum Zitat Migliore A, Tormenta S, Massafra U et al (2005) Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis Cartil 13(12):1126–1127CrossRef Migliore A, Tormenta S, Massafra U et al (2005) Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis Cartil 13(12):1126–1127CrossRef
33.
Zurück zum Zitat Migliore A, Tormenta S, Martin LS et al (2005) Open pilot study of ultrasound guided intra-articular injection of Hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24(3):285–289PubMedCrossRef Migliore A, Tormenta S, Martin LS et al (2005) Open pilot study of ultrasound guided intra-articular injection of Hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24(3):285–289PubMedCrossRef
34.
Zurück zum Zitat Migliore A, Tormenta S, Martin Martin LS et al (2006) The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25(3):389–393PubMedCrossRef Migliore A, Tormenta S, Martin Martin LS et al (2006) The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25(3):389–393PubMedCrossRef
35.
Zurück zum Zitat Migliore A, Tormenta S, Martin Martin LS et al (2004) Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip. Reumatismo 56(2):104–109PubMed Migliore A, Tormenta S, Martin Martin LS et al (2004) Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip. Reumatismo 56(2):104–109PubMed
36.
Zurück zum Zitat Migliore A, Tormenta S, Massafra U et al (2006) 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 58(1):39–49PubMed Migliore A, Tormenta S, Massafra U et al (2006) 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 58(1):39–49PubMed
37.
Zurück zum Zitat Migliore A, Tormenta S, Valenta C et al (2005) Intra-articular treatment with hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up. Reumatismo 57(1):36–43PubMed Migliore A, Tormenta S, Valenta C et al (2005) Intra-articular treatment with hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up. Reumatismo 57(1):36–43PubMed
38.
Zurück zum Zitat Pourbagher MA, Ozalay M, Pourbagher A (2005) Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 24:1391–1395PubMed Pourbagher MA, Ozalay M, Pourbagher A (2005) Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 24:1391–1395PubMed
39.
Zurück zum Zitat Qvistgaard E, Christensen R, Torp-Pedersen S et al (2006) Intra-articular treatment of hip osteoarthritis: a randomised trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartil 14(2):163–170CrossRef Qvistgaard E, Christensen R, Torp-Pedersen S et al (2006) Intra-articular treatment of hip osteoarthritis: a randomised trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartil 14(2):163–170CrossRef
40.
Zurück zum Zitat Schulz KF, Chalmers I, Grimes DA et al (1994) Assessing the quality of randomisation from reports of controlled trials published in obstetrics and gynaecology journals. JAMA 272:125–128PubMedCrossRef Schulz KF, Chalmers I, Grimes DA et al (1994) Assessing the quality of randomisation from reports of controlled trials published in obstetrics and gynaecology journals. JAMA 272:125–128PubMedCrossRef
41.
Zurück zum Zitat Tepper S, Hochberg MC (1993) Factors associated with hip osteoarthritis: Data from the first National Health and Nutrition Examination Survey (NHANES-1). Am J Epidemiol 137:1081–1088PubMed Tepper S, Hochberg MC (1993) Factors associated with hip osteoarthritis: Data from the first National Health and Nutrition Examination Survey (NHANES-1). Am J Epidemiol 137:1081–1088PubMed
42.
Zurück zum Zitat Thomas E, Peat G, Hill S et al (2004) The North Staffordshire Osteoarthritis Project-NorStop: prospective 3 year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 5:2PubMedCrossRef Thomas E, Peat G, Hill S et al (2004) The North Staffordshire Osteoarthritis Project-NorStop: prospective 3 year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 5:2PubMedCrossRef
43.
Zurück zum Zitat Tikiz C, Unlu Z, Sener A et al (2005) Comparison of the efficacy of lower and higher molecular weight viscosupplementation in treatment of hip osteoarthritis. Clin Rheumatol 24(3):244–250PubMedCrossRef Tikiz C, Unlu Z, Sener A et al (2005) Comparison of the efficacy of lower and higher molecular weight viscosupplementation in treatment of hip osteoarthritis. Clin Rheumatol 24(3):244–250PubMedCrossRef
44.
Zurück zum Zitat Vad VB, Sakalkale D, Sculco TP et al (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84(8):1224–1226PubMedCrossRef Vad VB, Sakalkale D, Sculco TP et al (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84(8):1224–1226PubMedCrossRef
45.
Zurück zum Zitat van den Bekerom MPJ, Mylle G, Rys B et al (2006) Viscosupplementation in symptomatic severe hip-osteoarthritis: A review of the literature and report on 60 patients. Acta Orthop Belg 72:560–566 van den Bekerom MPJ, Mylle G, Rys B et al (2006) Viscosupplementation in symptomatic severe hip-osteoarthritis: A review of the literature and report on 60 patients. Acta Orthop Belg 72:560–566
46.
Zurück zum Zitat Verhagen AP, de Vet HC, de Bie RA et al (1998) Balneotherapy and quality assessment: interobserver reliability of the Maastricht criteria list and the need for blinded quality assessment. J Clin Epid 51:335–341CrossRef Verhagen AP, de Vet HC, de Bie RA et al (1998) Balneotherapy and quality assessment: interobserver reliability of the Maastricht criteria list and the need for blinded quality assessment. J Clin Epid 51:335–341CrossRef
47.
Zurück zum Zitat Weiss C, Band P (1995) Musculoskeletal applications of hyaluron and hylan. Potential uses in the foot and ankle. Clin Pod Med Surg 12(3):497–517 Weiss C, Band P (1995) Musculoskeletal applications of hyaluron and hylan. Potential uses in the foot and ankle. Clin Pod Med Surg 12(3):497–517
Metadaten
Titel
What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature
verfasst von
Michel P. J. van den Bekerom
Bas Lamme
An Sermon
Michiel Mulier
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Archives of Orthopaedic and Trauma Surgery / Ausgabe 8/2008
Print ISSN: 0936-8051
Elektronische ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-007-0447-z

Weitere Artikel der Ausgabe 8/2008

Archives of Orthopaedic and Trauma Surgery 8/2008 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.